financetom
Business
financetom
/
Business
/
Israel's G. Willi-Food Q2 revenue rises on improved product availability, higher private label sales
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Israel's G. Willi-Food Q2 revenue rises on improved product availability, higher private label sales
Aug 12, 2025 5:50 AM

Overview

* Israeli-based G. Willi-Food's ( WILC ) Q2 sales rise 9.4% yr/yr to ILS 160.5 mln ($47.6 mln)

* Operating profit jumps 113.9% yr/yr due to reduced expenses

* Net profit surges 365.5% yr/yr to ILS 31.9 mln

Outlook

* Company expects new logistics center to be completed by early next year

* Company aims to expand into new food categories

* Willi-Food plans to maintain competitive pricing amid rising living costs

Result Drivers

* INVENTORY LEVELS - Increased inventory levels and improved product availability supported growing demand

* PRIVATE LABEL SALES - Higher private label sales to large retail chains contributed to sales growth

* EXPENSE REDUCTION - Operating profit boosted by reduced operating expenses and absence of prior year's financial sanction expense

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Sales ILS

160.50

mln

Q2 Net ILS

Income 31.90

mln

Q2 Basic ILS 2.3

EPS

Q2 Gross ILS 44

Profit mln

Q2 ILS

Operatin 20.60

g Profit mln

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved